Theranexus Société Anonyme's latest marketcap:
As of 07/20/2025, Theranexus Société Anonyme's market capitalization has reached $10.33 M. According to our data, Theranexus Société Anonyme is the 40453th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 10.33 M |
| Revenue (ttm) | 2.66 M |
| Net Income (ttm) | -2,053,229.46 |
| Shares Out | 8.54 M |
| EPS (ttm) | -0.24 |
| Forward PE | 2.35 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/25/2025 |
Theranexus Société Anonyme's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/20/2025 | €8.88 M | $10.33 M | 97.97% | 40453 |
| 12/31/2024 | €4.48 M | $4.64 M | -48.39% | 41118 |
| 12/29/2023 | €8.69 M | $9.59 M | -7.12% | 37287 |
| 12/30/2022 | €9.36 M | $10.01 M | -58.65% | 35938 |
| 12/31/2021 | €22.62 M | $25.71 M | -67.24% | 31455 |
| 12/31/2020 | €69.06 M | $84.34 M | 527.09% | 21583 |
| 12/31/2019 | €11.01 M | $12.35 M | -80.3% | 28210 |
| 12/31/2018 | €55.9 M | $64.09 M | 20.67% | 19648 |
| 12/29/2017 | €46.32 M | $55.56 M | 20991 |
Company Profile
About Theranexus Société Anonyme
Theranexus Société Anonyme is a biopharmaceutical company specializing in the development of innovative drug candidates for central nervous system (CNS) disorders. The company focuses on addressing unmet medical needs through cutting-edge research and clinical development.
Key Highlights
- Primary Focus: Development of treatments for CNS disorders.
- Lead Candidate: Batten-1, currently in Phase ½ clinical trials for Batten disease.
- Founded: 2013.
- Headquarters: Lyon, France.
Theranexus is committed to advancing therapeutic solutions that improve patient outcomes in neurological diseases.
Frequently Asked Questions
-
What is Theranexus Société Anonyme's (EPA-ALTHX) current market cap?As of 07/20/2025, Theranexus Société Anonyme (including the parent company, if applicable) has an estimated market capitalization of $10.33 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Theranexus Société Anonyme (EPA-ALTHX) rank globally by market cap?Theranexus Société Anonyme global market capitalization ranking is approximately 40453 as of 07/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.